The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Modified FOLFIRINOX for metastatic pancreatic adenocarcinoma after failure of nab-paclitaxel plus gemcitabine.
 
Masato Ozaka
Honoraria - Bayer; Novartis; Pfizer; Taiho Pharmaceutical; Yakult Honsha
 
Takashi Sasaki
No Relationships to Disclose
 
Seita Kataoka
No Relationships to Disclose
 
Ryo Kanata
No Relationships to Disclose
 
Kazunaga Ishigaki
No Relationships to Disclose
 
Ikuhiro Yamada
No Relationships to Disclose
 
Masato Matsuyama
No Relationships to Disclose
 
Koichi Takano
No Relationships to Disclose
 
Naoki Sasahira
Honoraria - Taiho Pharmaceutical
Research Funding - Eisai; Kyowa Hakko Kirin; Merck Serono; Taiho Pharmaceutical; Zeria Pharmaceutical